Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
Isocitrate dehydrogenase 1 (IDH1) mutations occur in approximately 13% of patients with intrahepatic cholangiocarcinoma. 185 patients were randomly as...
Cytoreductive surgery and HIPEC for malignant ascites from colorectal cancer - a randomized study
The efficacy of different timings of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in controlling malignant ascit...
Pharmacological ascorbate inhibits pancreatic cancer metastases via a peroxide-mediated mechanism
Pharmacological ascorbate (P-AscH-, high-dose, intravenous vitamin C) is cytotoxic to tumor cells in doses achievable in humans. Studies in pancreatic...
Randomised clinical trial: palliative long-term abdominal drains vs large-volume paracentesis in refractory ascites due to cirrhosis
Palliative care remains suboptimal in end-stage liver disease. Study assessed palliative long-term abdominal drains in liver disease to determine recr...
Randomised clinical trial: standard of care versus early-transjugular intrahepatic porto-systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding
Early-transjugular intrahepatic porto-systemic shunt (TIPSS) recommended in international guidelines for high-risk patients with oesophageal variceal...
A prospective, randomized trial of thrombin versus cyanoacrylate injection in the control of acute gastric variceal hemorrhage
Acute gastric variceal hemorrhage (AGVH) is a serious complication of portal hypertension. Glue injection is standard therapy for acute hemostasis, bu...
Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis
A total of 32 studies assessing 3952 patients were included in this meta-analysis. SSM was quite useful for ruling out the presence of HREV thereby av...
Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19
Elevated liver chemistries and pre-existing chronic liver disease (CLD) have been reported in COVID-19. The presence of CLD does not alter the outcome...